60 DEGREES PHARMA INC (SXTP) Stock Analyst Earnings Estimates
NASDAQ:SXTP - Nasdaq - US83006G2030 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.353M 191.23% | 511.21K -91.95% | 253.57K -50.40% | 612K 141.35% | 1.684M 175.16% | 3.88M 130.40% | |
| EBITDA YoY % growth | -1.093M -44.16% | -1.718M -57.11% | -5.104M -197.16% | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.124M -42.97% | -1.75M -55.72% | -5.155M -194.47% | -9.776M -89.65% | -7.97M 18.47% | -8.73M -9.54% | |
| Operating Margin | -17.69% | -342.41% | -2,032.81% | -1,597.33% | -473.26% | -225.00% | |
| EPS YoY % growth | N/A | N/A | N/A | -4.97 54.66% | -1.69 65.91% | -0.30 82.53% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.90 79.22% | -0.86 -338.00% | -0.82 80.71% | -0.75 18.84% | -0.64 28.41% |
| Revenue Q2Q % growth | 306K 616.46% | 306K 109.46% | 408K 226.40% | 612K 353.33% | 816K 166.67% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.902M -0.40% | -1.224M 8.08% | -1.122M 73.21% | -918K 56.67% | -918K 51.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.93 -110.06% | -0.72 | -0.21 | -29.33% |
| Q2 2024 Q2Q % growth | -4.23 | -2.85 | -1.38 | -48.37% |
| Q1 2024 Q2Q % growth | 0.36 | -1.84 | 2.20 | 119.61% |
| Q4 2023 Q2Q % growth | -4.32 | -2.51 | -1.81 | -72.17% |
| Q3 2023 Q2Q % growth | 9.24 | 11.63 | -2.39 | -20.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 135K 164.71% | 246.84K | -111.84K | -45.31% |
| Q2 2024 Q2Q % growth | 125K 99.52% | 215.73K | -90.73K | -42.06% |
| Q1 2024 Q2Q % growth | 146.09K 580.75% | 164.22K | -18.13K | -11.04% |
| Q4 2023 Q2Q % growth | 42.71K -91.65% | 76.5K | -33.79K | -44.17% |
| Q3 2023 Q2Q % growth | 51K -90.87% | 89.25K | -38.25K | -42.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -633.33% | 0% | 17.74% |
| Revenue | 0% | -14.29% | 0% | -34.25% |